Similar articles for PMID: 21395632

Year	Number of Results
1990	1
1995	1
1997	4
1998	2
1999	1
2000	2
2001	1
2002	1
2003	1
2004	3
2006	6
2007	6
2008	17
2009	12
2010	9
2011	19
2012	14
2013	6
2014	8
2015	11
2016	3
2017	3
2018	5
2019	3
2020	10
2021	8
2022	3
2023	1
2024	0

1

Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.

Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Qi X, et al. Aliment Pharmacol Ther. 2011 May;33(10):1087-103. doi: 10.1111/j.1365-2036.2011.04627.x. Epub 2011 Mar 13. Aliment Pharmacol Ther. 2011. PMID: 21395632 Free article.

2

Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.

Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, Liu Z, Bai W, Li R, Bai M, Yang Z, Wu K, Fan D. Qi X, et al. J Gastroenterol Hepatol. 2012 Jun;27(6):1036-43. doi: 10.1111/j.1440-1746.2011.07040.x. J Gastroenterol Hepatol. 2012. PMID: 22142461

3

Prevalence of JAK29V617F) mutation in intra-abdominal venous thrombosis.

Deepak A, Punamiya S, Patel N, Parekh S, Mehta S, Shah N. Deepak A, et al. Trop Gastroenterol. 2011 Oct-Dec;32(4):279-84. Trop Gastroenterol. 2011. PMID: 22696908

4

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gäken J, Wendon J, Heaton ND, Mufti GJ. Patel RK, et al. Gastroenterology. 2006 Jun;130(7):2031-8. doi: 10.1053/j.gastro.2006.04.008. Gastroenterology. 2006. PMID: 16762626

5

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Smalberg JH, et al. Blood. 2012 Dec 13;120(25):4921-8. doi: 10.1182/blood-2011-09-376517. Epub 2012 Oct 4. Blood. 2012. PMID: 23043069 Free article. Review.

6

JAK2 mutations across a spectrum of venous thrombosis cases.

Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K. Shetty S, et al. Am J Clin Pathol. 2010 Jul;134(1):82-5. doi: 10.1309/AJCP7VO4HAIZYATP. Am J Clin Pathol. 2010. PMID: 20551270

7

[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].

Fama A, Rago A, Gioiosa F, Marzano C, Latagliata R, Mammì C, Laganà C, D'Elia GM, Bizzoni L, Trasarti S, Ferretti A, Breccia M, Riggio O, Tafuri A. Fama A, et al. Clin Ter. 2010;161(2):169-71. Clin Ter. 2010. PMID: 20499034 Review. Italian.

8

Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.

Karaköse S, Oruç N, Zengin M, Akarca US, Ersöz G. Karaköse S, et al. Turk J Gastroenterol. 2015 Jan;26(1):42-8. doi: 10.5152/tjg.2015.5738. Turk J Gastroenterol. 2015. PMID: 25698270 Free article.

9

JAK2V617F mutation in patients with splanchnic vein thrombosis.

Xavier SG, Gadelha T, Pimenta G, Eugenio AM, Ribeiro DD, Gomes FM, Bonamino M, Zalcberg IR, Spector N. Xavier SG, et al. Dig Dis Sci. 2010 Jun;55(6):1770-7. doi: 10.1007/s10620-009-0933-y. Epub 2009 Aug 19. Dig Dis Sci. 2010. PMID: 19690956

10

Hypereosinophilia, JAK2V617F, and Budd-Chiari syndrome: who is responsible for what?

Mishchenko E, Tadmor T, Schiff E, Attias D, Polliack A. Mishchenko E, et al. Am J Hematol. 2011 Feb;86(2):223-4. doi: 10.1002/ajh.21926. Am J Hematol. 2011. PMID: 21264914 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year